Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00769002 · ClinicalTrials.gov registry record · NA
PET-CT Scans in Healthy Volunteers After Flu Vaccination
A NA study, sponsored by Hackensack Meridian Health.
- Terminated
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT00769002 is a NA study that was terminated before completion, run by Hackensack Meridian Health. The registered enrollment target is 18 participants.
The verdict
NCT00769002, a NA study, was terminated before completion, sponsored by Hackensack Meridian Health.
- TERMINATED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
This study is being done to learn how previous flu vaccination or previous infection with flu virus affects the immune response to vaccination.
Interventions
- PROCEDURE Blood Draws
- BIOLOGICAL FluShield
- BIOLOGICAL FluShield - same arm
- BIOLOGICAL FluShield - opposite arm
- PROCEDURE FDG PET-CT Scan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2008-09 |
| Est. Completion | 2011-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00769002
The ClinicalTrials.gov registry entry for NCT00769002 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hackensack Meridian Health, which has 90 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Blood Draws is the first listed.
NCT00769002 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00769002 about?
NCT00769002 is a clinical study titled "PET-CT Scans in Healthy Volunteers After Flu Vaccination". This study is being done to learn how previous flu vaccination or previous infection with flu virus affects the immune response to vaccination.
What is the current status of trial NCT00769002?
This trial is currently terminated. It is a NA study. The enrollment target is 18 participants. The study started on 2008-09. Estimated completion is 2011-08.
What interventions are being tested in trial NCT00769002?
The interventions under investigation include: Blood Draws (PROCEDURE), FluShield (BIOLOGICAL), FluShield - same arm (BIOLOGICAL), FluShield - opposite arm (BIOLOGICAL), FDG PET-CT Scan (PROCEDURE).
Who is sponsoring clinical trial NCT00769002?
This trial is sponsored by Hackensack Meridian Health, which has 90 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.